Federal grants to Inflammatix, Inc.
Inflammatix, Inc. in Sunnyvale, California received $2.3 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Biomedical Research and Research Training, with $1.7 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.3 million
- Awards3
- Awarded in FY 2025$0
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $935,259 |
| FY 2022 | 1 | $1.0 million |
| FY 2023 | 1 | $299,762 |
| FY 2024 | 0 | $0 |
| FY 2025 | 0 | $0 |
Programs that fund Inflammatix, Inc.
| Program | Awards | Amount |
|---|---|---|
| Biomedical Research and Research Training | 1 | $1.7 million |
| Cardiovascular Diseases Research | 1 | $299,762 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $251,371 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes - abstract sepsis, a systemic inflammatory condition, occurs as a complication of infection and in severe cases may be associated with acute and life-threatening organ dysfunction. In the us alone, sepsis cl | Biomedical Research and Research Training | August 5, 2021 | $1.7 million |
| Development of a multi-rna signature in blood towards a rapid diagnostic test to robustly distinguish patients with acute myocardial infarction - abstract chest pain, the main symptom of acute myocardial infarction (AMI), accounts for ~5% of all emergency department (ED) visits. In the absence of ec | Cardiovascular Diseases Research | June 28, 2023 | $299,762 |
| Development of baseline gene expression-based response predictor for anti-tnfa therapy in patients with inflammatory bowel diseases - abstract anti-tnfa therapies are widely used to treat autoimmune diseases, including inflammatory bowel disease (IBD), a chronic inflammation of the digestive system | Diabetes, Digestive, and Kidney Diseases Extramural Research | December 24, 2020 | $251,371 |
Questions people ask
How much federal grant money does Inflammatix, Inc. get?
$2.3 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Inflammatix, Inc. the most?
The Department of Health and Human Services, with $2.3 million in 3 awards.
What is Inflammatix, Inc.'s largest federal grant?
$1.7 million under Biomedical Research and Research Training, with its first action in the period on August 5, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Inflammatix, Inc.?
Its largest are Biomedical Research and Research Training, Cardiovascular Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Sunnyvale
- Eridan Communications Inc
- Antora Energy, Inc.
- City of Sunnyvale
- Acellent Technologies Inc
- Petcoil, Inc
- Resurge International
- Larix Bioscience LLC
- Insight M Inc.
Largest federal grant recipients in California · Federal grants in California